Subcommittee on Neurological Disease committee  Thanks very much. Thanks to all of you. I'd like to begin with Dr. Zamboni's conclusions, which I think are worth repeating because they inform a lot of where a lot of the people in the room feel we need to go. They are as follows: CCSVI exists and is a serious

Health committee   and so, as you can well imagine, scientific research is of great importance to me. One of the studies on CCSVI subsidized by the Multiple Sclerosis Society of Canada focuses, in particular, on whether chronic cerebrospinal venous insufficiency is a cause of multiple sclerosis

Health committee   that there was something we immediately needed to look into concerning this possible treatment. So we launched our own request for proposals to look at the relationship between CCSVI and MS. We were the first organization in the world to issue a request for research proposals on CCSVI and MS

Health committee   situation, so it's a huge issue, which the federal government can directly assist with. That's not going to be my question, but I wanted you to know that we've heard everything you're saying. The questions I have focus more on where we're at with the CCSVI. We've all been visited

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. The petitioners understand that the government will fund a trial but question the non-announcement announcement. Who was the research team? Why phase I-II when three FDA phase II studies are under way

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. Thirty thousand treatments have been undertaken in 60 countries, while Canada has failed to begin clinical trials. The U.S. is already undertaking three FDA approved clinical trials. The U.K. encourages robust

Petitions   call upon the Minister of Health to consult experts who have practical experience in dealing with CCSVI. They urge the minister to proceed with phase III clinical trials on an urgent basis. They also urge the minister to require follow-up of patients with Doppler ultrasound

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. Former deputy surgeon general and director general of the Laboratory Centre for Disease Control, Dr. Michael Shannon, writes: Having lived through the restructuring of the Canadian Blood System in the late 90

Health committee  Thank you. I also want to go back to the MS monitoring system, which Ms. Elmslie spoke about, that was announced in March 2011. I know my colleague asked whether or not we will be tracking all Canadians who have received the CCSVI treatment. I want to know if you can expand

Health committee  Thank you very much. I'll start by saying that, as you know, the monitoring system is for all MS patients, including those who have chosen to have the CCSVI procedure, but not exclusive to those patients. The reason it's important to have this monitoring system is that right

Health committee   1,000 patients. We just heard a discussion about how we don't know how to do the imaging. I was at the International Society for Neurovascular Disease conference a week ago, where I gave two talks. You will see the positive and negative studies linking CCSVI in my rebuttal

Health committee  Thank you very much, Madame Chair. I want to thank the witnesses for being here again to update us on this very important study. I did want to touch base with you, Dr. Beaudet. Could you give the committee a rundown of the progress made in the last year on CCSVI? I know you

Health committee  , in 2009, Italian physician Paolo Zamboni proposed that the blockage of veins in the neck and chest, a condition he referred to as chronic cerebrospinal venous insufficiency, or CCSVI, was the cause of MS, and he suggested that opening these veins would relieve the patients' MS symptoms

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  The House resumed from February 15 consideration of the motion that Bill C-280, An Act to establish a National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI), be read the second time and referred to a committee.

Multiple Sclerosis  Mr. Speaker, 55,000 to 75,000 Canadians live with devastating MS. Tonight, all members will have the opportunity to vote their conscience, to do the right thing and to vote to develop a national strategy for CCSVI. Sixty countries have undertaken 30,000 procedures, while Canada